SUBSCRIBERS
Big Pharma losing price leverage amid squeeze by payers
Latest quarterly results raise pressure on drugmakers to pump up sales volumes, find lucrative new treatments
Published Thu, May 4, 2017 · 09:50 PM
New York
BEING a big drug company isn't what it used to be.
The largest drugmakers are finding it more difficult to charge high prices for a range of medications, their latest quarterly results show. That's raising the pressure to pump up sales volumes and find lucrative new treatments for niche markets.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Australia’s retail sales volumes fall 0.4% in Q1
Possible class action lawsuit against Cordlife by customers could take at least 2 years
Chinese tariffs could leave cognac makers with too much brandy
Holiday Inn owner IHG’s Q1 revenue up 2.6%, leisure travel demand remains strong
WSJ moves Asia headquarters from Hong Kong to Singapore